iShares Biotechnology ETF
852 hedge funds and large institutions have $8.89B invested in iShares Biotechnology ETF in 2020 Q4 according to their latest regulatory filings, with 142 funds opening new positions, 263 increasing their positions, 269 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
852
Holders Change
+71
Holders Change %
+9.09%
% of All Funds
15.12%
Holding in Top 10
15
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.76%
% of All Funds
0.27%
New
142
Increased
263
Reduced
269
Closed
58
Calls
$818M
Puts
$1.5B
Net Calls
-$684M
Net Calls Change
-$362M
Top Buyers
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$682M |
| 2 |
Goldman Sachs
New York
|
+$399M |
| 3 |
Morgan Stanley
New York
|
+$167M |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$151M |
| 5 |
Citigroup
New York
|
+$60.5M |
Top Sellers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$415M |
| 2 |
JPMorgan Chase & Co
New York
|
-$238M |
| 3 |
Barclays
London,
United Kingdom
|
-$106M |
| 4 |
N
Natixis
Paris,
France
|
-$67.7M |
| 5 |
Squarepoint
New York
|
-$29.3M |